Ryan Troup

Ryan Troup is the Editor in Chief of Wealthy VC. Ryan has 15+ years of investing experience. X | Email
Top Stories

The Winners and Losers From This Week’s Earnings

This week’s earnings reports painted a mixed picture across industries, with some companies outperforming expectations while others faltered amid shifting…

Read More »
Biotech

Quantum BioPharma Reports Successful Clinical Trial Results for Alcohol Detox Drink unbuzzd, QNTM Stock Soars 111% on 600X Volume

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) announced today the completion of its double-blind, randomized, placebo-controlled crossover…

Read More »
Tech

Why Nvidia Stock Suffered the Largest Ever Single-Day Loss in History

Nvidia (NASDAQ: NVDA), a name synonymous with artificial intelligence (AI) and cutting-edge computing, made history on Monday—but not for the…

Read More »
Tech

Trump TikTok Ban Extension Sees New Big-Name Buyers Emerge

In yet another twist to the ongoing TikTok saga, President Donald Trump signed an executive order granting ByteDance, TikTok’s Chinese…

Read More »
Crypto

How to Trade Bitcoin Options: A Beginner’s Guide

In the ever-evolving world of cryptocurrency, Bitcoin remains the flagship digital asset. While many are familiar with buying and holding…

Read More »
Crypto

Why Trump’s Memecoin and Bitcoin Hit Record Highs on Inauguration Day

On a historic inauguration day, the cryptocurrency market experienced an electrifying surge, led by a record-breaking performance by Bitcoin (BTCUSD)…

Read More »
Featured

Sober Up, Buttercup: Why Quantum BioPharma’s Alcohol Detox Drink ‘unbuzzd’ is a Game-Changer

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) is redefining how we recover from alcohol consumption with its revolutionary product,…

Read More »
Consumer

Insurance Nightmare: Why Thousands Had Policies Canceled Before LA Wildfires

When the Los Angeles wildfires erupted, reducing thousands of homes to ash and leaving countless families displaced, a secondary crisis…

Read More »
Tech

Why Currenc Group (CURR) Stock Skyrocketed 400% Today

Currenc Group (NASDAQ: CURR) stock experienced an incredible surge on Wednesday, climbing over 400% following the announcement of its cutting-edge…

Read More »
Biotech

Quantum BioPharma Approved to Dual List on Upstream Global Trading App

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) announced it was approved to dual list its shares on the Upstream…

Read More »
Back to top button